New York, US – January 8th, 2019 As the world leading custom CellRapeutics™ Chimeric Antigen Receptor (CAR) service provider, Creative Biolabs, recently released Biomarker Identification & Selection Services.
As the most promising approach, Chimeric antigen receptor (CAR)-engineered T cell therapy has shown remarkable ability to eliminate various kinds of tumors, bringing new hope for numerous cancer patients all over the world. Cancer biomarkers in CAR-T therapy are not only involved in the canceration process but also correlated with the disease changes, like deterioration and improvement, which provides the most prominent signal of cancer cells for distinguishing from normal cells and the most effective target for immune recognition and destruction.
Creative Biolabs provide almost all the discovered cancer targets and novel ones in the evaluation for CAR-T therapy, like AFP for liver cancer, BCR-ABL for chronic myeloid leukemia, BRCA1/BRCA2 for breast/ovarian cancer, BRAF V600E for melanoma/colorectal cancer, CA-125 for ovarian cancer, CA19.9 for pancreatic cancer, CEA for colorectal cancer, EGFR for non-small-cell lung carcinoma, HER-2 for breast cancer, KIT for gastrointestinal stromal tumor, PSA for prostate cancer, S100 for melanoma, etc.
“In the process of working with our clients, our specialized scientists will recommend the most applicable target according to specific type of cancer and customs requirements, or design subsequent and further technique service based on designated target. Novel potential targets are screened based on customized conditions, which is an advanced optional service with relatively higher technique requirement,” said the manager engaged in Creative Biolabs.
Based on advanced technology and years of research, Creative Biolabs offers high-quality custom service covering the entire CAR-T therapy development process including but not limited to:
· Biomarker Identification & Selection
· High Affinity ScFv Generation
· CAR Design & Construction
· Virus Packaging & CAR Gene Delivery
· CAR-T In Vitro Assay
· CAR-T Preclinical In Vivo Assay
· CAR-T Clinical Trail
Equipped with the advanced technology and platform, CBL can customize any product or service related to CAR-T therapy to meet all specific and unique requirements, which can greatly assist research, preclinical investigation and clinical stage development.
About Creative Biolabs
As a global company, Creative Biolabs has more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, the established leading experts in TCR and CAR-T&NK cell immune therapy development offer the one-stop custom services that cover the entire new drug development pipeline, and an exclusive line of ready-to-use TCR and CAR-T&NK cell construction products, such as virus packaging, purification, expansion and titer determination kits. Furthermore, a unique unparalleled CAR construction and production platform has been built up for all four CAR generations.
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States